Filtros de búsqueda

Lista de obras de Iris Y Navarro-Millán

Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial

artículo científico publicado en 2015

Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration

artículo científico publicado en 2015

Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment

scientific article published on 11 April 2018

Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.

artículo científico publicado en 2013

Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial.

artículo científico publicado en 2013

Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability

artículo científico publicado en 2016

Dose escalation of certolizumab pegol from 200 mg to 400 mg every other week provides no additional efficacy in rheumatoid arthritis: an analysis of individual patient-level data.

artículo científico publicado en 2011

Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial

artículo científico publicado en 2016

Newest clinical trial results with antitumor necrosis factor and nonantitumor necrosis factor biologics for rheumatoid arthritis

artículo científico

Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient Reported Outcome Data Collection: A Qualitative Study.

artículo científico publicado en 2018

Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial ⬇️

artículo científico publicado el 13 de octubre de 2011

Predictors and persistence of new-onset clinical remission in rheumatoid arthritis patients.

artículo científico publicado en 2013

Reconstructing the population history of Puerto Rico by means of mtDNA phylogeographic analysis

artículo científico publicado en 2005

Reply - "Anakinra for COVID-19: how to interpret elevations in liver enzymes"

scientific article published on 20 September 2020

Screening of Hyperlipidemia among Patients with Rheumatoid Arthritis in the United States

artículo científico publicado en 2019

Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor

artículo científico publicado en 2012

Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis

scientific article published on 22 October 2013

Toward a Core Domain Set for Glucocorticoid Impact in Inflammatory Rheumatic Diseases: The OMERACT 2018 Glucocorticoid Impact Working Group

scientific article published on 15 January 2019

Toward development of a point-of-care assay of enoxaparin anticoagulant activity in whole blood

scientific article published on 01 July 2011

Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series

artículo científico publicado en 2020

Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and Portugal

artículo científico publicado en 2009

Views of primary care physicians and rheumatologists regarding screening and treatment of hyperlipidemia among patients with rheumatoid arthritis

artículo científico publicado en 2020

Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?

scientific article published on 05 September 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda